Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Page 1
Universality of Squashed-Sphere Partition Functions.
Bueno P, Cano PA, Hennigar RA, Mann RB. Bueno P, et al. Among authors: hennigar ra. Phys Rev Lett. 2019 Feb 22;122(7):071602. doi: 10.1103/PhysRevLett.122.071602. Phys Rev Lett. 2019. PMID: 30848622
Finally, based on holographic results and free-field numerical calculations, we conjecture that the subleading term in the squashing-parameter free-energy expansion is universally controlled by the stress-tensor three-point function charge t_{4} for general (2+1)-dimension …
Finally, based on holographic results and free-field numerical calculations, we conjecture that the subleading term in the squashing- …
Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.
Page EK, Page AJ, Kwun J, Gibby AC, Leopardi F, Jenkins JB, Strobert EA, Song M, Hennigar RA, Iwakoshi N, Knechtle SJ. Page EK, et al. Among authors: hennigar ra. Am J Transplant. 2012 Sep;12(9):2395-405. doi: 10.1111/j.1600-6143.2012.04074.x. Epub 2012 Jul 9. Am J Transplant. 2012. PMID: 22776408 Free PMC article.
Chronic allograft rejection is a major impediment to long-term transplant success. Humoral immune responses to alloantigens are a growing clinical problem in transplantation, with mounting evidence associating alloantibodies with the development of chronic rejection. ...
Chronic allograft rejection is a major impediment to long-term transplant success. Humoral immune responses to alloantigens are a gro …
A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.
Tumlin JA, Miller D, Near M, Selvaraj S, Hennigar R, Guasch A. Tumlin JA, et al. Among authors: hennigar r. Clin J Am Soc Nephrol. 2006 Jan;1(1):109-16. doi: 10.2215/CJN.00120605. Epub 2005 Nov 30. Clin J Am Soc Nephrol. 2006. PMID: 17699197 Clinical Trial.
Sirolimus is a novel immunosuppressive agent that is structurally related to tacrolimus but demonstrates no long-term nephrotoxicity. For determination of the efficacy of sirolimus in reducing proteinuria, a prospective, open-label trial was conducted of 21 patients with i …
Sirolimus is a novel immunosuppressive agent that is structurally related to tacrolimus but demonstrates no long-term nephrotoxicity. …
Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
Tumlin JA, Hennigar RA. Tumlin JA, et al. Among authors: hennigar ra. Semin Nephrol. 2004 May;24(3):256-68. doi: 10.1016/j.semnephrol.2004.01.006. Semin Nephrol. 2004. PMID: 15156530
Seventeen patients underwent repeat kidney biopsies after 6 months of therapy, and the morphologic response to treatment was assessed using a modified systemic lupus erythematosis (SLE) histologic activity and chronicity index score. To determine the long-term efficacy of …
Seventeen patients underwent repeat kidney biopsies after 6 months of therapy, and the morphologic response to treatment was assessed using …
Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines.
Slade RF, Hunt DA, Pochet MM, Venema VJ, Hennigar RA. Slade RF, et al. Among authors: hennigar ra. Anticancer Res. 2003 Mar-Apr;23(2B):1235-43. Anticancer Res. 2003. PMID: 12820377
Finally, the FAS inhibitor cerulenin was investigated for its ability to suppress tumor cell growth. After four days of propagation, short-term treatment of cell lines with drug produced mean IC50s less than 10.5 micrograms/ml (i.e., 5.6 +/- 1.9 for SM II; 9.3 +/- 1.5 for …
Finally, the FAS inhibitor cerulenin was investigated for its ability to suppress tumor cell growth. After four days of propagation, short- …
Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
Tumlin JA, Lohavichan V, Hennigar R. Tumlin JA, et al. Among authors: hennigar r. Nephrol Dial Transplant. 2003 Jul;18(7):1321-9. doi: 10.1093/ndt/gfg081. Nephrol Dial Transplant. 2003. PMID: 12808169 Clinical Trial.
Endocapillary proliferation, cellular crescents and karyorrhexis were eliminated in all 12 patients after 6 months of therapy, while interstitial fibrosis and tubule dropout remained unchanged. To determine the long-term efficacy of the treatment, treated patients were com …
Endocapillary proliferation, cellular crescents and karyorrhexis were eliminated in all 12 patients after 6 months of therapy, while interst …
Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival.
Gansler TS, Hardman W 3rd, Hunt DA, Schaffel S, Hennigar RA. Gansler TS, et al. Among authors: hennigar ra. Hum Pathol. 1997 Jun;28(6):686-92. doi: 10.1016/s0046-8177(97)90177-5. Hum Pathol. 1997. PMID: 9191002
Similar median survival values were obtained when cases were limited to endometrioid, serous, and mucinous carcinomas. Short-term survival at 1 and 2 years was significantly higher in patients whose tumors showed no or focal expression of FAS compared with multifocal/diffu …
Similar median survival values were obtained when cases were limited to endometrioid, serous, and mucinous carcinomas. Short-term sur …